<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/132357</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;132357</article-id><article-id pub-id-type="other" hwp:sub-type="slug">132357</article-id><article-id pub-id-type="other" hwp:sub-type="tag">132357</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Bioinformatics" hwp:journal="biorxiv"><subject>Bioinformatics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Signaling Pathway Activities Improve Prognosis for Breast Cancer</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label>To whom correspondence should be addressed.</corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Jiao Yunlong"><surname>Jiao</surname><given-names>Yunlong</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Hidalgo Marta R."><surname>Hidalgo</surname><given-names>Marta R.</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Çubuk Cankut"><surname>Çubuk</surname><given-names>Cankut</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Amadoz Alicia"><surname>Amadoz</surname><given-names>Alicia</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Carbonell-Caballero José"><surname>Carbonell-Caballero</surname><given-names>José</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-3" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Vert Jean-Philippe"><surname>Vert</surname><given-names>Jean-Philippe</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-7"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3318-120X</contrib-id><name name-style="western" hwp:sortable="Dopazo Joaquín"><surname>Dopazo</surname><given-names>Joaquín</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-3318-120X"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>1</label><institution hwp:id="institution-1">MINES ParisTech, PSL Research University, Centre for Computational Biology</institution>, 77300 Fontainebleau, <country>France</country>;</aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2"><label>2</label><institution hwp:id="institution-2">Institut Curie</institution>, 75248 Paris Cedex, <country>California</country>;</aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2"><label>3</label><institution hwp:id="institution-3">INSERM, U900</institution>, 75248 Paris Cedex, <country>France</country>;</aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2"><label>4</label><institution hwp:id="institution-4">Ecole Normale Supérieure, Department of Mathematics and their Applications</institution>, 75005 Paris, <country>France</country>;</aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2 xref-aff-5-3"><label>5</label><institution hwp:id="institution-5">Computational Genomics Department, Centro de Investigación Príncipe Felipe (CIPF)</institution>, 46012 Valencia, <country>Spain</country>;</aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2"><label>6</label><institution hwp:id="institution-6">Clinical Bioinformatics Research Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocío</institution>, 41013, Sevilla, <country>Spain</country>;</aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1"><label>7</label><institution hwp:id="institution-7">Functional Genomics Node (INB), FPS, Hospital Virgen del Rocío</institution>, 41013 Sevilla, <country>Spain</country>;</aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1"><label>8</label><institution hwp:id="institution-8">Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocío</institution>, 41013, Sevilla, <country>Spain</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2017"><year>2017</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2017-04-29T14:24:14-07:00">
    <day>29</day><month>4</month><year>2017</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2017-04-29T14:24:14-07:00">
    <day>29</day><month>4</month><year>2017</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2017-04-29T14:45:17-07:00">
    <day>29</day><month>4</month><year>2017</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2017-04-29T14:45:17-07:00">
    <day>29</day><month>4</month><year>2017</year>
  </pub-date><elocation-id>132357</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2017-04-29"><day>29</day><month>4</month><year>2017</year></date>
<date date-type="accepted" hwp:start="2017-04-29"><day>29</day><month>4</month><year>2017</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2017</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/" hwp:id="license-1"><p hwp:id="p-1">This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by/4.0/</ext-link></p></license></permissions><self-uri xlink:href="132357.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/132357v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="132357.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/132357v1/132357v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/132357v1/132357v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">With the advent of high-throughput technologies for genome-wide expression profiling, a large number of methods have been proposed to discover gene-based signatures as biomarkers to guide cancer prognosis. However, it is often difficult to interpret the list of genes in a prognostic signature regarding the underlying biological processes responsible for disease progression or therapeutic response. A particularly interesting alternative to gene-based biomarkers is mechanistic biomarkers, derived from signaling pathway activities, which are known to play a key role in cancer progression and thus provide more informative insights into cellular functions involved in cancer mechanism. In this study, we demonstrate that pathway-level features, such as the activity of signaling circuits, outperform conventional gene-level features in prediction performance in breast cancer prognosis. We also show that the proposed classification scheme can even suggest, in addition to relevant signaling circuits related to disease outcome, a list of genes that do not code for signaling proteins whose contribution to cancer prognosis potentially supplements the mechanisms detected by pathway analysis.</p></abstract><counts><page-count count="15"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">Introduction</title><p hwp:id="p-3">Over the past decades, many efforts have been addressed to the identification of gene-based signatures to predict patient prognosis using gene expression data (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">Paik, et al., 2004</xref>; <xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">Sotiriou and Pusztai, 2009</xref>; <xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">van ′t Veer, et al., 2002</xref>; <xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">Wang, et al., 2005</xref>). Despite the success of its use, gene expression signatures have not been exempt of problems (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">Ein-Dor, et al., 2006</xref>; <xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">Iwamoto and Pusztai, 2010</xref>). Specifically, one major drawback of multi-gene biomarkers is that they often lack proper interpretation in terms of mechanistic link to the fundamental cell processes responsible for disease progression or therapeutic response (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">Dopazo, 2010</xref>; <xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">van′t Veer and Bernards, 2008</xref>). Actually, it is increasingly recognized that complex traits, such as disease or drug response, are better understood as alterations in the operation of functional modules caused by different combinations of gene perturbations (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">Barabasi, et al., 2011</xref>; <xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">Barabasi and Oltvai, 2004</xref>; <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">Oti and Brunner, 2007</xref>). To address this inherent complexity different methodologies have tried to exploit several functional module conceptual representations, such as protein interaction networks or pathways, to interpret gene expression data within a systems biology context (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">Barabasi, et al., 2011</xref>; <xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">Fryburg, et al., 2014</xref>; <xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">Hood, 2013</xref>; <xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">Vidal, et al., 2011</xref>). Actually, it has recently been shown that the pathway-level representation generates clinically relevant stratifications and outcome predictors for glioblastoma and colorectal cancer (<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">Drier, et al., 2013</xref>) and also breast cancer (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">Livshits, et al., 2015</xref>). Moreover, mathematical models of the activity of a pathway have demonstrated a significantly better association to poor prognosis in neuroblastoma patients than the activity of their constituent genes, including <italic toggle="yes">MICN</italic>, a conventional biomarker (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">Fey, et al., 2015</xref>). This observation has recently been extended to other cancers (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>) and to the prediction of drug effects (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">Amadoz, et al., 2015</xref>).</p><p hwp:id="p-4">Given that the inferred activity of the pathway should be closely related to its cellular mechanism for disease progression, its use to guide cancer prognosis seems promising. Recently, a number of pathway activity inference methods have been proposed (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>; <xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">Jacob, et al., 2012</xref>; <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">Li, et al., 2015</xref>; <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">Martini, et al., 2013</xref>). Here, we use the canonical circuit activity analysis method, which has demonstrated to have a superior performance (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-3" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>) finding significant associations of specific circuit activities, directly responsible for triggering the prominent cancer hallmarks (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">Hanahan and Weinberg, 2011</xref>), to patient survival. This method recodes gene expression values into measurements of signaling circuit activities that ultimately account for cell responses to specific stimuli. Such activity values can be considered multigenic mechanistic biomarkers that can be used as features for cancer prognosis.</p><p hwp:id="p-5">We demonstrate that the activity of signaling circuits yields comparable or even better prediction in breast cancer prognosis than the expression of individual genes, while detected mechanistic biomarkers enjoy the compelling advantage of readily available interpretation in terms of the corresponding cellular functions they trigger. Moreover, we show that the proposed prediction scheme can even suggest, in addition to interesting signaling circuits related to disease outcome, a list of prognostic genes that do not code for signaling proteins whose contribution to cancer prognosis potentially supplements the mechanism included in the pathways modeled.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-3">Methods</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-4">Data source and processing</title><p hwp:id="p-6">The breast cancer gene expression and survival data used here was downloaded from The Cancer Genome Atlas (TCGA), release No. 20 of the International Cancer Genome Consortium (ICGC) data portal (<ext-link l:rel="related" l:ref-type="uri" l:ref="https://dcc.icgc.org/releases/release_20/Projects/BRCA-US" ext-link-type="uri" xlink:href="https://dcc.icgc.org/releases/release_20/Projects/BRCA-US" hwp:id="ext-link-2">https://dcc.icgc.org/releases/release_20/Projects/BRCA-US</ext-link>). This dataset provides the RNA-seq counts of 18,708 genes for 879 tumor samples, in which we also have records of the vital status of corresponding donors, namely the overall survival outcome of the cancer patients being alive or deceased at the end of clinical treatment (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>). Since TCGA cancer data are from different origins and underwent different management processes, non-biological experimental variations, commonly known as batch effect, associated to Genome Characterization Center (GCC) and plate ID must be removed from the RNA-seq data. The COMBAT method (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">Johnson, et al., 2007</xref>) was used for this purpose. We then applied the trimmed mean of M-values normalization method (TMM) method (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">Robinson and Oshlack, 2010</xref>) for data normalization which is essential in applying the CCAA method. The resulting normalized values were finally entered to the pathway analysis method.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2 xref-table-wrap-1-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><p hwp:id="p-7">Summary of survival outcome of the breast cancer patients in the TCGA dataset.</p></caption><graphic xlink:href="132357_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></table-wrap><p hwp:id="p-8">A total of 60 KEGG pathways (Supplementary <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>) were downloaded from the KEGG repository (<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">Kanehisa, et al., 2012</xref>), including 2,212 gene products that participate in 3,379 nodes.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-5">Modeling framework for signaling pathways</title><p hwp:id="p-9">We applied the canonical circuit activity analysis method (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-4" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>), as implemented in the <italic toggle="yes">hipathia</italic> R package available at <ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/babelomics/hipathia" ext-link-type="uri" xlink:href="https://github.com/babelomics/hipathia" hwp:id="ext-link-3">https://github.com/babelomics/hipathia</ext-link>, in pursuit of modeling signaling activity. Within the modeling context, a <italic toggle="yes">circuit</italic> is defined as all possible routes the signal can traverse to be transmitted from a particular input node to a particular output node (see Supplementary <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1A</xref>). A total of 6,101 <italic toggle="yes">circuits</italic> are identified and modeled in this study. The transmission of the signal depends on the integrity of the chain of nodes that connect the receptor to the effector and briefly, it is estimated as follows. The presence of the mRNA (the normalized RNA-seq counts rescaled between 0 and 1) is taken as a proxy for the presence of the corresponding protein in each pathway node (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">Bhardwaj and Lu, 2005</xref>; <xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">Efroni, et al., 2007</xref>; <xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">Montaner, et al., 2009</xref>; <xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">Sebastian-Leon, et al., 2014</xref>). Then, the degree of integrity of the <italic toggle="yes">circuit</italic> is estimated by modeling the signal flow across it. Specifically, the input node (receptor) is initialized by an incoming signal of intensity value of 1, and then for each node <italic toggle="yes">n</italic> of the <italic toggle="yes">circuit</italic>, the signal value <italic toggle="yes">sn</italic> is updated by the following rule:
<disp-formula id="eqn1" hwp:id="disp-formula-1"><alternatives hwp:id="alternatives-1"><graphic xlink:href="132357_eqn1.gif" position="float" orientation="portrait" hwp:id="graphic-2"/></alternatives></disp-formula>
where <italic toggle="yes">An</italic> denotes the set of signals arriving to the node from activation edges, <italic toggle="yes">In</italic> denotes the set of signals arriving to the node from inhibition edges, and <italic toggle="yes">vn</italic> is the (normalized) value of the current node <italic toggle="yes">n</italic>.</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig. 1.</label><caption hwp:id="caption-2"><title hwp:id="title-6">The AUROC performance of using different types of profiles as predictive features to classify survival outcome for breast cancer patients.</title><p hwp:id="p-10">Boxplot represents the variance of the performance on 50 cross-validation splits. Dotted vertical lines separate profiles by the underlying analysis levels.</p></caption><graphic xlink:href="132357_fig1" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-11">Finally, the activity value for the <italic toggle="yes">circuit</italic> is defined by the signal intensity transmitted through the last (effector) protein of the circuit which quantifies the cell function ultimately activated by the <italic toggle="yes">circuit</italic>.</p><p hwp:id="p-12">Since output nodes at the end of <italic toggle="yes">circuits</italic> are the ultimate triggers of specific cellular actions, an <italic toggle="yes">effector circuit</italic> is defined from a functional viewpoint as a higher-level signaling entity that composes all <italic toggle="yes">circuits</italic> ending at the same output node. When applied to an effector circuit, the method returns the joint intensity of the signal arriving to the corresponding effector node (see Supplementary <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Figure 1B</xref>). Furthermore, the known functions triggered by each effector protein in cell can be derived from their functional annotations. Here we use UniProt (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">UniProt_Consortium, 2015</xref>) and Gene Ontology (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">Ashburner, et al., 2000</xref>) (GO) annotations.</p><p hwp:id="p-13">Finally, inferred signaling activity values of those effector circuits ending at proteins with the same annotated functions are averaged to quantify the activity of the function realized in cell. This way we obtain estimated activity values directly connected to a list of cellular functions (Supplementary <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Figure 1C</xref>).</p><p hwp:id="p-14">Supplementary <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Figure 1</xref> depicts the different levels of abstraction from <italic toggle="yes">circuits</italic>, to <italic toggle="yes">effector circuits</italic> and finally functions. Eventually, a subset of curated functions can be used for a specific scenario in which the relevant functions are known. Here we use cancer hallmarks (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-2" hwp:rel-id="ref-26">Hanahan and Weinberg, 2011</xref>).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-7">Cancer prognosis with inferred signaling pathway activity</title><p hwp:id="p-15">In this study, we are interested in evaluating the prognostic power of pathway-level mechanistic features and gene-based features alone and in combination. Using the <italic toggle="yes">hipathia</italic> method we recoded the list of gene expression values of each tumor sample into the corresponding lists of signaling activity values for the three levels of abstraction: <italic toggle="yes">circuits, effector circuits</italic> and functions, as described in UniProt and GO annotations. Therefore for each tumor sample we end up with a profile of gene expression, a profile of <italic toggle="yes">circuit</italic> signaling activity, a profile of <italic toggle="yes">effector circuit</italic> signaling activity, a profile of UniProt-based cellular function activity and a profile of GO-based cellular function activity. These profiles are sample-specific profiles that can be straightforwardly used as prognostic features using any classification algorithm. Note that pathway-level profiles are derived with no regard to any information provided by the genes whose products do not participate in cell signaling, and the prognostic power of pathway-level profiles may thus be limited by the coverage of genes in known biological pathways. In order to understand the relative contribution to the pathway-level profiles and gene-level profiles to the accurate separation between good vs poor prognosis, we devised four artificial profiles: <italic toggle="yes">path-gene</italic> expression profile containing only genes that are involved in the KEGG signaling pathways, <italic toggle="yes">other-gene</italic> expression profile containing only genes that are absent from the KEGG pathways, a combined profile consisting of signaling activity of effector circuits and expression of other-genes, and a combined profile consisting of signaling activity of <italic toggle="yes">circuits</italic> and expression of other-genes. Thus, we use a total of 9 types of profiles (detailed in <xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref>) From the viewpoint of machine learning, this study is formulated as a typical binary classification problem where we determine a positive or negative pseudo label for each sample. Based on the data available in this study (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-3" hwp:rel-id="T1">Table 1</xref>) we perform a 5-fold cross-validation repeated 10 times on the dataset and report the mean performance over the 5 <italic toggle="yes">×</italic> 10 = 50 splits to assess the prognostic power for each type of profile. The performance is evaluated by the Area Under the ROC Curve (AUROC) criteria (<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">Sing, et al., 2005</xref>). Note that usually a classifier returns a continuous prediction between 0 and 1 for each sample denoting the probability of that sample being in the positive class rather than in the negative class, and then assigns either label to the sample according to some cutoff value thresholding the prediction. In fact, AUROC is a cutoff-free score that measures the probability that the classifier will score a randomly drawn positive sample higher than a randomly drawn negative sample.</p><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2 xref-table-wrap-2-3 xref-table-wrap-2-4 xref-table-wrap-2-5 xref-table-wrap-2-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-3"><p hwp:id="p-16">Summary of different types of profiles used as predictive features for breast cancer prognosis in this study.</p></caption><graphic xlink:href="132357_tbl2" position="float" orientation="portrait" hwp:id="graphic-4"/></table-wrap><p hwp:id="p-17">In this study we consider 12 classification algorithms as candidate classifiers, most of which are state-of-the-art (<xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Table 3</xref>). When we assess the prognosis performance for a specific type of profile on a specific (external) cross-validation split of the data, we perform an internal 5-fold cross-validation on the training set to determine which classifier returns the highest cross-validated performance and the best classifier is then used on the test set to obtain the performance score. This procedure guarantees that the performance on each (external) cross-validation split is evaluated impartially for each profile with its best suited algorithm.</p><table-wrap id="tbl3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1 xref-table-wrap-3-2 xref-table-wrap-3-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tbl3</object-id><label>Table 3.</label><caption hwp:id="caption-4"><p hwp:id="p-18">The 12 classifiers considered in this study to classify prognosis for breast tumor samples. Note that majority voting classifier serves as a baseline negative-control model which outputs a constant label for any test sample by the dominant class in the training set..</p></caption><graphic xlink:href="132357_tbl3" position="float" orientation="portrait" hwp:id="graphic-5"/></table-wrap></sec></sec><sec id="s3" hwp:id="sec-6"><title hwp:id="title-8">Results</title><sec id="s3a" hwp:id="sec-7"><label>3.1</label><title hwp:id="title-9">Signaling pathway activity leads to improved prognosis for breast tumor samples</title><p hwp:id="p-19">The performance of using different types of profiles (<xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2">Table 2</xref>) as predictive features to classify survival outcome for breast cancer patients is shown in <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Figure 1</xref> Under either criterion of AUROC to evaluate the classification performance, we observe that the activity values of signaling <italic toggle="yes">circuits,</italic> denoted by <italic toggle="yes">path.vals</italic>, yield the best performance overall. In particular, they outperform the profiles based solely on gene expression values, denoted by <italic toggle="yes">path.genes.vals, other.genes.vals</italic> and <italic toggle="yes">genes.vals</italic>. In other words, we are able to integrate the expression values of <italic toggle="yes">path-genes</italic> into the <italic toggle="yes">a priori</italic> knowledge of cell signaling to obtain pathway-level features that achieve improved prognosis. Interestingly, these pathway-level features relate to biological processes and cellular functions <italic toggle="yes">per se</italic>. Although the pathway-level features are derived from the expression of <italic toggle="yes">path-genes</italic> and thus agnostic to the expression of <italic toggle="yes">other-genes</italic>, the inclusion of <italic toggle="yes">other-genes</italic> to the signaling circuits activity values, denoted by <italic toggle="yes">eff.and.other.genes.vals</italic> and <italic toggle="yes">path.and.other.genes.vals</italic> profiles, does not significantly improve the performance (no significant differences after applying a two-sided t-test comparing differences between the cross-validation AUROC scores obtained by each pair of profiles, and adjusted for multiple testing (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">Benjamini and Hochberg, 1995</xref>), see <xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-1" hwp:rel-id="T4">Table 4</xref>).</p><table-wrap id="tbl4" orientation="portrait" position="float" hwp:id="T4" hwp:rev-id="xref-table-wrap-4-1 xref-table-wrap-4-2 xref-table-wrap-4-3 xref-table-wrap-4-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tbl4</object-id><label>Table 4.</label><caption hwp:id="caption-5"><p hwp:id="p-20">FDR-adjusted p-values comparing the corresponding classification scores of feature s in columns versus features in files over 50 cross-validation splits. See <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Figure 1</xref> for the performance values of each feature. Significant values are in boldface and marked with an asterisk..</p></caption><graphic xlink:href="132357_tbl4" position="float" orientation="portrait" hwp:id="graphic-6"/></table-wrap><p hwp:id="p-21">When comparing the prognostic power between pathway-level and gene-level profiles, we have also derived cellular function activity profiles, denoted by <italic toggle="yes">fun.vals</italic> and <italic toggle="yes">go.vals</italic> (<xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-3" hwp:rel-id="T2">Table 2</xref>), and observed that the performance of these profiles are slightly worse than other pathway-level profiles (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig. 1</xref>). This is probably due to the excessively simplistic procedure that basically averages the signaling activity values of effector circuits ending at proteins with the same annotated keywords according to Uniprot or GO (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-5" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>), annotations that can be incomplete and ambiguous to some extent.</p><p hwp:id="p-22"><xref rid="tbl5" ref-type="table" hwp:id="xref-table-wrap-5-1" hwp:rel-id="T5">Table 5</xref> summarizes the best-performing classifiers for each type of prognostic profile in the sense that they are most frequently selected by internal cross-validation. Notably, it evidences that Support Vector Machines with various kernels are recurrently selected as the competent classifier in breast cancer prognosis that suits well for both gene-level and pathway-level features.</p><table-wrap id="tbl5" orientation="portrait" position="float" hwp:id="T5" hwp:rev-id="xref-table-wrap-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T5</object-id><object-id pub-id-type="publisher-id">tbl5</object-id><label>Table 5.</label><caption hwp:id="caption-6"><p hwp:id="p-23">Top two most frequently selected classifiers by internal cross-validation for each type of prognostic profile in classifying breast cancer prognosis evaluated by AUROC.</p></caption><graphic xlink:href="132357_tbl5" position="float" orientation="portrait" hwp:id="graphic-7"/></table-wrap></sec><sec id="s3b" hwp:id="sec-8"><label>3.2</label><title hwp:id="title-10">Signaling circuits selected as features relevant for cancer prognostic account for cancer hallmarks</title><p hwp:id="p-24">From the clinical standpoint of cancer prognosis, we are interested in identifying a small set of biomarkers that can guide decision making in cancer prognosis. As our analysis is made at the level of pathways, we would like to detect a few signaling <italic toggle="yes">circuits</italic> whose activity, and thus the underlying cell functionality, has a significant impact on discriminating the prognosis classes of cancer patients. We opted for the Random Forest classifier to perform this analysis, since it simultaneously predicts the survival outcome of tumor samples and scores the importance of each feature that is ultimately used in the prediction. We focus on the feature importance measure returned by fitting a Random Forest which accounts for the mean decrease in classification performance if we randomly permute the data of the corresponding feature. <xref rid="tbl6" ref-type="table" hwp:id="xref-table-wrap-6-1" hwp:rel-id="T6">Table 6</xref> lists the five top-scored signaling <italic toggle="yes">circuits</italic> by fitting Random Forests with the profiles of <italic toggle="yes">circuit</italic> activities (denoted by <italic toggle="yes">path.vals</italic>). The role played by each signaling circuit in cancer progression can be inferred from the underlying cellular functions (taken from GO annotations) triggered by the last (effector) protein on the circuit. Thus, the first <italic toggle="yes">circuit</italic>, belonging to the <italic toggle="yes">HIF-1 signaling pathway</italic>, starts with the <italic toggle="yes">TLR4</italic> receptor, which is known to be related to progression of several cancers (breast, ovarian, prostate and head and neck) via Lipopolysaccharide Stimulation (<xref ref-type="bibr" rid="c69" hwp:id="xref-ref-69-1" hwp:rel-id="ref-69">Yang, et al., 2014</xref>) and ends in the <italic toggle="yes">EDN1</italic> effector, an hypoxia-inducible factor that mediates cancer progression (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">Semenza, 2012</xref>). Another relevant <italic toggle="yes">circuit</italic> belongs to the <italic toggle="yes">NF-kappa B signaling pathway</italic> and has the <italic toggle="yes">IL1B</italic> protein as receptor and the <italic toggle="yes">CXCL2</italic> as effector. Polymorphisms in the receptor have been linked to several cancers in different populations (<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">El-Omar, et al., 2000</xref>; Lu, et al., 2005) and it has been demonstrated the role of <italic toggle="yes">CXCL2</italic> in tumor growth and angiogenesis (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">Keane, et al., 2004</xref>). Similarly, polymorphisms in the <italic toggle="yes">LEP</italic> protein, the receptor of another <italic toggle="yes">circuit</italic> in the <italic toggle="yes">Adipocytokine signaling pathway</italic>, have been linked to cancer (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">Cleveland, et al., 2010</xref>), and its effector, the tyrosine phosphatase Shp2 (<italic toggle="yes">PTPN11</italic>), contributes to the pathogenesis of many cancers and other human diseases (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">Chan, et al., 2008</xref>). The Cell cycle signaling pathway contains another relevant <italic toggle="yes">circuit</italic> whose receptor <italic toggle="yes">TTK</italic> transmits the signal until the cohesin complex. This four proteins complex is essential for chromosome segregation and DNA repair and mutations in its component genes have recently been identified in several types of tumors (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">Losada, 2014</xref>). Finally, the fifth most relevant <italic toggle="yes">circuit</italic>, belonging to the <italic toggle="yes">Tight junction pathway,</italic> contains the <italic toggle="yes">AKT3</italic> serine/threonine kinase with a known role in tumorigenesis (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">Testa and Bellacosa, 2001</xref>), is signaled by the receptor <italic toggle="yes">ACTN4</italic>, a protein which has been related to cell invasion and metastasis (<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">Honda, 2015</xref>). Supplementary <xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-4" hwp:rel-id="T2">Table 2</xref> shows an expanded list of top-scored 50 <italic toggle="yes">circuits</italic>.</p><table-wrap id="tbl6" orientation="portrait" position="float" hwp:id="T6" hwp:rev-id="xref-table-wrap-6-1 xref-table-wrap-6-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T6</object-id><object-id pub-id-type="publisher-id">tbl6</object-id><label>Table 6.</label><caption hwp:id="caption-7"><p hwp:id="p-25">Top five <italic toggle="yes">circuits</italic> with the highest feature importance measure by fitting Random Forests with <italic toggle="yes">path.vals</italic> in classifying breast cancer prognosis.</p></caption><graphic xlink:href="132357_tbl6" position="float" orientation="portrait" hwp:id="graphic-8"/></table-wrap><p hwp:id="p-26"><xref rid="tbl7" ref-type="table" hwp:id="xref-table-wrap-7-1" hwp:rel-id="T7">Table 7</xref> lists the top-scored <italic toggle="yes">effector circuits</italic> by fitting Random Forests with the profiles of <italic toggle="yes">effector circuit</italic> activities (denoted by <italic toggle="yes">eff.vals</italic>). Although the cohesion complex effector is again selected, the effector circuit level analysis provided a slightly different perspective of relevant aspects of signaling in cancer patient survival. Thus, two <italic toggle="yes">effector circuits</italic> with effector proteins <italic toggle="yes">LEPR</italic> and <italic toggle="yes">PPARα</italic>, from the <italic toggle="yes">AMPK</italic> and the <italic toggle="yes">Adipocytokine</italic> signaling pathways, respectively, are activators of the fatty acid metabolism. Two more effector pathways ending in the Interleukin 6 (IL6), related to inflammatory processes and immune response in the <italic toggle="yes">Toll-like receptor pathway</italic>, seem more likely to be involved in blocking the cell differentiation through the <italic toggle="yes">Pathways in cancer</italic> (KEGG id hsa05200). Actually, it has been described that <italic toggle="yes">IL6</italic> blocks apoptosis in cells during the inflammatory process, keeping them alive in toxic environments, but the same process protects cells from apoptosis and chemotherapeutic drugs during neoplastic growth (<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">Hodge, et al., 2005</xref>). Supplementary <xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-2" hwp:rel-id="T3">Table 3</xref> shows an expanded list of top-scored 50 <italic toggle="yes">effector circuits</italic>. Beyond the top scored <italic toggle="yes">signaling circuits</italic> (<xref rid="tbl6" ref-type="table" hwp:id="xref-table-wrap-6-2" hwp:rel-id="T6">Table 6</xref>) and <italic toggle="yes">effector circuits</italic> (<xref rid="tbl7" ref-type="table" hwp:id="xref-table-wrap-7-2" hwp:rel-id="T7">Table 7</xref>), other relevant circuits are listed in Supplementary <xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-5" hwp:rel-id="T2">Tables 2</xref> and <xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-3" hwp:rel-id="T3">3</xref>. Although an exhaustive list of the consequences that processes differentially activated can have in tumorigenesis is beyond the scope of this work, it is worth noticing that cancer a hallmark such as apoptosis inhibition is represented by inhibition of <italic toggle="yes">signaling circuits IL6-BCL2</italic> in the <italic toggle="yes">HIF-1 signaling pathway</italic> and IL10-BNIP3 in the <italic toggle="yes">FoxO signaling pathway</italic> (eighth and ninth in Supplementary <xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-6" hwp:rel-id="T2">Table 2</xref>, respectively), both containing the protein <italic toggle="yes">STAT3</italic>, known to mediate apoptosis inhibition in breast cancer (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">Gritsko, et al., 2006</xref>) (see <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2</xref>). The graphic representation of the complete <italic toggle="yes">effector circuits</italic> containing the two <italic toggle="yes">signaling circuits</italic> in the <italic toggle="yes">HIF-1 signaling pathway</italic> and the <italic toggle="yes">FoxO signaling pathway</italic> has been obtained with the hipathia web tool (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-6" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>), using the <italic toggle="yes">path.genes.vals</italic> gene expression profiles (that are converted to <italic toggle="yes">eff.vals</italic> and <italic toggle="yes">path.vals</italic> profiles by the program).</p><table-wrap id="tbl7" orientation="portrait" position="float" hwp:id="T7" hwp:rev-id="xref-table-wrap-7-1 xref-table-wrap-7-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL7</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T7</object-id><object-id pub-id-type="publisher-id">tbl7</object-id><label>Table 7.</label><caption hwp:id="caption-8"><p hwp:id="p-27">Top five <italic toggle="yes">effector circuits</italic> with the highest feature importance measure by fitting Random Forests with <italic toggle="yes">eff.vals</italic> in classifying breast cancer prognosis.</p></caption><graphic xlink:href="132357_tbl7" position="float" orientation="portrait" hwp:id="graphic-9"/></table-wrap><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig. 2.</label><caption hwp:id="caption-9"><title hwp:id="title-11"><italic toggle="yes">Effector circuits</italic> containing <italic toggle="yes">Signaling circuits IL6-BCL2</italic> in the <italic toggle="yes">HIF-1 signaling pathway</italic> and <italic toggle="yes">IL10-BNIP3</italic> in the <italic toggle="yes">FoxO signaling pathway</italic>, both highlighted in the figure.</title><p hwp:id="p-28">Both <italic toggle="yes">circuits</italic> contain the protein <italic toggle="yes">STAT3</italic>, known to mediate apoptosis inhibition in breast cancer.</p></caption><graphic xlink:href="132357_fig2" position="float" orientation="portrait" hwp:id="graphic-10"/></fig></sec><sec id="s3c" hwp:id="sec-9"><label>3.3</label><title hwp:id="title-12">The classification algorithm suggests additional prognostic genes that do not code for signaling proteins</title><p hwp:id="p-29">In order to find genes that could be relevant for patient survival that are not in the signal pathways, we build a profile by combining signaling circuit activity profiles and gene expression profiles corresponding to genes outside signaling pathways (the <italic toggle="yes">other-genes</italic> profile), denoted by <italic toggle="yes">path.and.other.genes.vals.</italic> A feature selection procedure in breast cancer prognosis based on such a profile can select signaling circuits along with genes unrelated to signaling, whose activity is related to patient survival. Thus, Random Forest was again used to assess feature importance when fit with the <italic toggle="yes">path.and.other.genes.vals</italic> profile to classify survival outcome. <xref rid="tbl8" ref-type="table" hwp:id="xref-table-wrap-8-1" hwp:rel-id="T8">Table 8</xref> lists the top 5 most important gene features (the <italic toggle="yes">other-genes</italic> part of the <italic toggle="yes">path.and.other.genes.vals</italic> composed profile). These genes are of particular interest given that they might represent relevant cancer processes not included in cell signaling. Notably, the gene <italic toggle="yes">ABCB5</italic> belongs to the ATP-binding cassette subfamily B which is well known to be involved in multiple drug resistance in cancer therapy (<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">Dean, et al., 2001</xref>), probably because its functionality of efflux transmembrane transporter. It has also been reported that <italic toggle="yes">ABCB5</italic> could mediate cell-to-cell fusion and contribute to breast cancer chemoresistance in expressing breast tumors (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">Frank, et al., 2005</xref>; <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">Frank, et al., 2003</xref>). In addition, <italic toggle="yes">ABCB5</italic>, as a “pro-survival” gene, has been suggested to be a potential target against drug resistant breast cancer cells (<xref ref-type="bibr" rid="c70" hwp:id="xref-ref-70-1" hwp:rel-id="ref-70">Yang, et al., 2010</xref>). Besides, ABCB5 has been linked to melanoma (<xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">Wilson, et al., 2014</xref>). <italic toggle="yes">LMO4</italic> encodes a LIM-domain protein that has been reported as an essential mediator of cell cycle progression in ErbB2/HER2/Neu-induced breast cancer which is characterized by poor survival due to high proliferation and metastasis rates (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">Matthews, et al., 2013</xref>; <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">Montañez-Wiscovich, et al., 2009</xref>). It has been reported that <italic toggle="yes">LMO4</italic> interacts with the renowned tumor suppressor <italic toggle="yes">BRCA1</italic> and inhibits <italic toggle="yes">BRCA1</italic> activity (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">Sum, et al., 2002</xref>; <xref ref-type="bibr" rid="c58" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">Sutherland, et al., 2003</xref>). <italic toggle="yes">OPA1</italic> encodes a mitochondrial fusion protein which might be a target for mitochondrial apoptotic effectors (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">Olichon, et al., 2003</xref>), such as sorafenib (<xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-1" hwp:rel-id="ref-72">Zhao, et al., 2013</xref>). The role in cancer survival played by two most important genes according to the predictor, <italic toggle="yes">VPS72</italic> and <italic toggle="yes">CHADL,</italic> is not as clear from the literature. It is worth mentioning that a mutation in VPS72 in cervix cancer with a high FATHMM pathogenicity score (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">Shihab, et al., 2015</xref>) is described in the COSMIC database (entry COSM458603). Regarding <italic toggle="yes">CHADL</italic>, it has been related to chondrocyte differentiation (<xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">Tillgren, et al., 2015</xref>) and extracellular matrix remodeling (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">Barallobre-Barreiro, et al., 2012</xref>). Therefore, both genes are potentially involved in cancer processes, which suggest that further investigation of the complete list of top-ranked <italic toggle="yes">other-genes</italic> could render new cancer drivers and potential therapeutic targets. An expanded list containing the top 50 most important features among the <italic toggle="yes">other-genes</italic> can be found in Supplementary <xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-2" hwp:rel-id="T4">Table 4</xref>, in which many genes with cancer-related functions can be seen. Functions for the genes have been taken from their Uniprot (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-2" hwp:rel-id="ref-62">UniProt_Consortium, 2015</xref>) annotations and, when absent, from GeneCards annotations (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">Stelzer, et al., 2016</xref>).</p><table-wrap id="tbl8" orientation="portrait" position="float" hwp:id="T8" hwp:rev-id="xref-table-wrap-8-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;132357v1/TBL8</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T8</object-id><object-id pub-id-type="publisher-id">tbl8</object-id><label>Table 8.</label><caption hwp:id="caption-10"><p hwp:id="p-30">Top five genes unrelated to signaling ranked by importance in the classification of survival outcome by fitting Random Forests with <italic toggle="yes">path.and.other.genes.vals</italic> profile, along their functions as annotated in Gene Ontology.</p></caption><graphic xlink:href="132357_tbl8" position="float" orientation="portrait" hwp:id="graphic-11"/></table-wrap></sec><sec id="s3d" hwp:id="sec-10"><label>3.4</label><title hwp:id="title-13">Availability of data and results</title><p hwp:id="p-31">All experiments are produced with R and codes are available via <ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/YunlongJiao/hipathiaCancerPrognosis" ext-link-type="uri" xlink:href="https://github.com/YunlongJiao/hipathiaCancerPrognosis" hwp:id="ext-link-4">https://github.com/YunlongJiao/hipathiaCancerPrognosis</ext-link>.</p><p hwp:id="p-32">There is an R package available at <ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/babelomics/hipathia" ext-link-type="uri" xlink:href="https://github.com/babelomics/hipathia" hwp:id="ext-link-5">https://github.com/babelomics/hipathia</ext-link>. Additionally, there is a web interface to the hipathia methodology that includes prediction functionalities, which is freely available at: <ext-link l:rel="related" l:ref-type="uri" l:ref="http://hipathia.babelomics.org/" ext-link-type="uri" xlink:href="http://hipathia.babelomics.org/" hwp:id="ext-link-6">http://hipathia.babelomics.org/</ext-link>.</p></sec></sec><sec id="s4" hwp:id="sec-11"><title hwp:id="title-14">Conclusions</title><p hwp:id="p-33">In this study we have proposed a novel scheme to classify survival outcome for breast cancer patients based on mechanistic features consisting of signaling pathway activity profiles. We applied a pathway activity analysis method (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-7" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>) to recode gene expression profiles into activity values of signaling circuits and demonstrated that, making use of the state-of-the-art computational tools, signaling circuit activity yields better prediction in breast cancer prognosis than gene expression. An additional advantage is that the identified pathway-level biomarkers are mechanistic signatures whose contribution to cancer progression can be readily interpreted in terms of the underlying cellular functions and biological processes.</p><p hwp:id="p-34">The three feature sets <italic toggle="yes">path.genes.vals, eff.vals</italic> and <italic toggle="yes">path.vals</italic> are composed by the same genes (those present in the pathways). However, the prediction performance of the genes recoded into circuits activity values with the hipathia method (<italic toggle="yes">eff.vals</italic> and <italic toggle="yes">path.vals</italic>) clearly outperforms (see <xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-3" hwp:rel-id="T4">Table 4</xref>) to those of the original genes (<italic toggle="yes">path.genes.vals</italic>). Moreover, predictors based on circuits (<italic toggle="yes">eff.vals</italic> and <italic toggle="yes">path.vals</italic>) have similar performance (see <xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-4" hwp:rel-id="T4">Table 4</xref>) to predictors based on all the genes (<italic toggle="yes">genes.vals</italic>), which include more information than the subset of genes. It is worth noting that genes in the circuits represent only 12% of the total number of genes, but have the same predictive performance, which suggests that combining the genes into circuits provides a real added value for prediction purposes.</p><p hwp:id="p-35">Although a significant improvement of the performance was not observed when the expression values of <italic toggle="yes">other-genes</italic> were concatenated to the activity values of signaling circuits, the analysis based on the combination of both data provides an interesting perspective regarding the interpretation of the biomarkers detected. In fact, the selected genes from the category of <italic toggle="yes">other-genes</italic> represent other aspects of the mechanism of the disease not explained by cell signaling. This approach allows expanding the scope of the analysis beyond the processes included in the pathways modeled.</p><p hwp:id="p-36">Central to our proposed scheme is the idea of promoting gene-level analysis to pathway-level analysis by obtaining patient-specific personalized profiles of signaling circuit activity. Reliable models of pathway activity (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-8" hwp:rel-id="ref-27">Hidalgo, et al., 2017</xref>) can be used to derive robust multigenic biomarkers, similar to the popular MammaPrint (van′t Veer and Bernards, 2008), which in addition account properly for the underlying disease mechanisms or mechanisms of drug action.</p></sec></body><back><sec id="s5" hwp:id="sec-12"><title hwp:id="title-15">Funding</title><p hwp:id="p-37">This work was supported by the European Union 7th Framework Program through the Marie Curie ITN MLPM grant No 316861, by the European Research Council grant ERC-SMAC-280032, by grants BIO2014-57291-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 from the ISCIII, both co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE (ref. 676559)</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-16">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Amadoz A."><surname>Amadoz</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-2">Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity</article-title>, <source hwp:id="source-1">Scientific reports</source>, <volume>5</volume>, <fpage>18494</fpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Ashburner M."><surname>Ashburner</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2000</year>) <article-title hwp:id="article-title-3">Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>, <source hwp:id="source-2">Nat Genet</source>, <volume>25</volume>, <fpage>25</fpage>–<lpage>29</lpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Barabasi A.L."><surname>Barabasi</surname>, <given-names>A.L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gulbahce N."><surname>Gulbahce</surname>, <given-names>N.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Loscalzo J."><surname>Loscalzo</surname>, <given-names>J.</given-names></string-name> (<year>2011</year>) <article-title hwp:id="article-title-4">Network medicine: a network-based approach to human disease</article-title>, <source hwp:id="source-3">Nat Rev Genet</source>, <volume>12</volume>, <fpage>56</fpage>–<lpage>68</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Barabasi A.L."><surname>Barabasi</surname>, <given-names>A.L.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Oltvai Z.N."><surname>Oltvai</surname>, <given-names>Z.N.</given-names></string-name> (<year>2004</year>) <article-title hwp:id="article-title-5">Network biology: understanding the cell’s functional organization</article-title>, <source hwp:id="source-4">Nat Rev Genet</source>, <volume>5</volume>, <fpage>101</fpage>–<lpage>113</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><citation publication-type="other" citation-type="journal" ref:id="132357v1.5" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Barallobre-Barreiro J."><surname>Barallobre-Barreiro</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title hwp:id="article-title-6">Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia-reperfusion injury</article-title>, <source hwp:id="source-5">Circulation, CIRCULATIONAHA. 111.056952</source>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Benjamini Y."><surname>Benjamini</surname>, <given-names>Y.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Hochberg Y."><surname>Hochberg</surname>, <given-names>Y.</given-names></string-name> (<year>1995</year>) <article-title hwp:id="article-title-7">Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>, <source hwp:id="source-6">Journal of the Royal Statistical Society. Series B</source>, <volume>57</volume>, <fpage>289</fpage>–<lpage>300</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Bhardwaj N."><surname>Bhardwaj</surname>, <given-names>N.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Lu H."><surname>Lu</surname>, <given-names>H.</given-names></string-name> (<year>2005</year>) <article-title hwp:id="article-title-8">Correlation between gene expression profiles and protein— protein interactions within and across genomes</article-title>, <source hwp:id="source-7">Bioinformatics</source>, <volume>21</volume>, <fpage>2730</fpage>–<lpage>2738</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Breiman L."><surname>Breiman</surname>, <given-names>L.</given-names></string-name> (<year>2001</year>) <article-title hwp:id="article-title-9">Random Forests</article-title>, <source hwp:id="source-8">Machine Learning</source>, <volume>45</volume>, <fpage>5</fpage>–<lpage>32</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Cleveland R.J."><surname>Cleveland</surname>, <given-names>R.J.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>) <article-title hwp:id="article-title-10">Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival</article-title>, <source hwp:id="source-9">Breast cancer research and treatment</source>, <volume>120</volume>, <fpage>745</fpage>–<lpage>752</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Chan G."><surname>Chan</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kalaitzidis D."><surname>Kalaitzidis</surname>, <given-names>D.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Neel B.G."><surname>Neel</surname>, <given-names>B.G.</given-names></string-name> (<year>2008</year>) <article-title hwp:id="article-title-11">The tyrosine phosphatase Shp2 (PTPN11) in cancer</article-title>, <source hwp:id="source-10">Cancer and metastasis reviews</source>, <volume>27</volume>, <fpage>179</fpage>–<lpage>192</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Chang C.-C."><surname>Chang</surname>, <given-names>C.-C.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Lin C.-J."><surname>Lin</surname>, <given-names>C.-J.</given-names></string-name> (<year>2011</year>) <article-title hwp:id="article-title-12">LIBSVM: a library for support vector machines</article-title>, <source hwp:id="source-11">ACM Transactions on Intelligent Systems and Technology (TIST)</source>, <volume>2</volume>, <fpage>27</fpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Dean M."><surname>Dean</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamon Y."><surname>Hamon</surname>, <given-names>Y.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Chimini G."><surname>Chimini</surname>, <given-names>G.</given-names></string-name> (<year>2001</year>) <article-title hwp:id="article-title-13">The human ATP-binding cassette (ABC) transporter superfamily</article-title>, <source hwp:id="source-12">Journal of lipid research</source>, <volume>42</volume>, <fpage>1007</fpage>–<lpage>1017</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Dopazo J."><surname>Dopazo</surname>, <given-names>J.</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-14">Functional profiling methods in cancer</article-title>, <source hwp:id="source-13">Methods Mol Biol</source>, <volume>576</volume>, <fpage>363</fpage>–<lpage>374</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Drier Y."><surname>Drier</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sheffer M."><surname>Sheffer</surname>, <given-names>M.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Domany E."><surname>Domany</surname>, <given-names>E.</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-15">Pathway-based personalized analysis of cancer</article-title>, <source hwp:id="source-14">Proceedings of the National Academy of Sciences</source>, <volume>110</volume>, <fpage>6388</fpage>–<lpage>6393</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Efroni S."><surname>Efroni</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schaefer C.F."><surname>Schaefer</surname>, <given-names>C.F.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Buetow K.H."><surname>Buetow</surname>, <given-names>K.H.</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-16">Identification of key processes underlying cancer phenotypes using biologic pathway analysis</article-title>, <source hwp:id="source-15">PLoS ONE</source>, <volume>2</volume>, <fpage>e425</fpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Ein-Dor L."><surname>Ein-Dor</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zuk O."><surname>Zuk</surname>, <given-names>O.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Domany E."><surname>Domany</surname>, <given-names>E.</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-17">Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer</article-title>, <source hwp:id="source-16">Proc Natl Acad Sci U S A</source>, <volume>103</volume>, <fpage>5923</fpage>–<lpage>5928</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="El-Omar E.M."><surname>El-Omar</surname>, <given-names>E.M.</given-names></string-name>, <etal>et al.</etal> (<year>2000</year>) <article-title hwp:id="article-title-18">Interleukin-1 polymorphisms associated with increased risk of gastric cancer</article-title>, <source hwp:id="source-17">Nature</source>, <volume>404</volume>, <fpage>398</fpage>–<lpage>402</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Fan R.-E."><surname>Fan</surname>, <given-names>R.-E.</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>) <article-title hwp:id="article-title-19">LIBLINEAR: A library for large linear classification</article-title>, <source hwp:id="source-18">Journal of machine learning research</source>, <volume>9</volume>, <fpage>1871</fpage>–<lpage>1874</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Fey D."><surname>Fey</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-20">Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients</article-title>, <source hwp:id="source-19">Sci Signal</source>, <volume>8</volume>, <fpage>ra130</fpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Frank N.Y."><surname>Frank</surname>, <given-names>N.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>) <article-title hwp:id="article-title-21">ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma</article-title>, <source hwp:id="source-20">Cancer research</source>, <volume>65</volume>, <fpage>4320</fpage>–<lpage>4333</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Frank N.Y."><surname>Frank</surname>, <given-names>N.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2003</year>) <article-title hwp:id="article-title-22">Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter</article-title>, <source hwp:id="source-21">Journal of Biological Chemistry</source>, <volume>278</volume>, <fpage>47156</fpage>–<lpage>47165</lpage>.</citation></ref><ref id="c22" hwp:id="ref-22"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Friedman J."><surname>Friedman</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hastie T."><surname>Hastie</surname>, <given-names>T.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Tibshirani R."><surname>Tibshirani</surname>, <given-names>R.</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-23">Regularization paths for generalized linear models via coordinate descent</article-title>, <source hwp:id="source-22">Journal of Statistical Software</source>, <volume>33</volume>, <fpage>1</fpage>.</citation></ref><ref id="c23" hwp:id="ref-23"><citation publication-type="other" citation-type="journal" ref:id="132357v1.23" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Friedman J.H."><surname>Friedman</surname>, <given-names>J.H.</given-names></string-name> (<year>2001</year>) <article-title hwp:id="article-title-24">Greedy function approximation: a gradient boosting machine</article-title>, <source hwp:id="source-23">Annals of Statistics</source>, <fpage>1189</fpage>–<lpage>1232</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Fryburg D.A."><surname>Fryburg</surname>, <given-names>D.A.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title hwp:id="article-title-25">Systems diagnostics: anticipating the next generation of diagnostic tests based on mechanistic insight into disease</article-title>, <source hwp:id="source-24">Drug Discov Today</source>, <volume>19</volume>, <fpage>108</fpage>–<lpage>112</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Gritsko T."><surname>Gritsko</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>) <article-title hwp:id="article-title-26">Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells</article-title>, <source hwp:id="source-25">Clinical Cancer Research</source>, <volume>12</volume>, <fpage>11</fpage>–<lpage>19</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1 xref-ref-26-2"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Hanahan D."><surname>Hanahan</surname>, <given-names>D.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Weinberg R.A."><surname>Weinberg</surname>, <given-names>R.A.</given-names></string-name> (<year>2011</year>) <article-title hwp:id="article-title-27">Hallmarks of cancer: the next generation</article-title>, <source hwp:id="source-26">Cell</source>, <volume>144</volume>, <fpage>646</fpage>–<lpage>674</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2 xref-ref-27-3 xref-ref-27-4 xref-ref-27-5 xref-ref-27-6 xref-ref-27-7 xref-ref-27-8"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Hidalgo M.R."><surname>Hidalgo</surname>, <given-names>M.R.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title hwp:id="article-title-28">High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes</article-title>, <source hwp:id="source-27">Oncotarget</source>, <volume>8</volume>, <fpage>5160</fpage>–<lpage>5178</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Hodge D.R."><surname>Hodge</surname>, <given-names>D.R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hurt E.M."><surname>Hurt</surname>, <given-names>E.M.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Farrar W.L."><surname>Farrar</surname>, <given-names>W.L.</given-names></string-name> (<year>2005</year>) <article-title hwp:id="article-title-29">The role of IL-6 and STAT3 in inflammation and cancer</article-title>, <source hwp:id="source-28">European journal of cancer</source>, <volume>41</volume>, <fpage>2502</fpage>–<lpage>2512</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Honda K."><surname>Honda</surname>, <given-names>K.</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-30">The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer</article-title>, <source hwp:id="source-29">Cell &amp; bioscience</source>, <volume>5</volume>, <fpage>41</fpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Hood L."><surname>Hood</surname>, <given-names>L.</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-31">Systems biology and p4 medicine: past, present, and future</article-title>, <source hwp:id="source-30">Rambam Maimonides medical journal</source>, <volume>4</volume>, <fpage>e0012</fpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Iwamoto T."><surname>Iwamoto</surname>, <given-names>T.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Pusztai L."><surname>Pusztai</surname>, <given-names>L.</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-32">Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?</article-title>, <source hwp:id="source-31">Genome medicine</source>, <volume>2</volume>, <fpage>81</fpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Jacob L."><surname>Jacob</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neuvial P."><surname>Neuvial</surname>, <given-names>P.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Dudoit S."><surname>Dudoit</surname>, <given-names>S.</given-names></string-name> (<year>2012</year>) <article-title hwp:id="article-title-33">More power via graph-structured tests for differential expression of gene networks</article-title>, <source hwp:id="source-32">Ann. Appl. Stat</source>., <volume>6</volume>, <fpage>561</fpage>–<lpage>600</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.33" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Jiao Y."><surname>Jiao</surname>, <given-names>Y.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Vert J.-P."><surname>Vert</surname>, <given-names>J.-P.</given-names></string-name> (<year>2016</year>) <article-title hwp:id="article-title-34">The Kendall and Mallows kernels for permutations</article-title>. <source hwp:id="source-33">HAL</source>. pp. <fpage>hal-01279273</fpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Johnson W.E."><surname>Johnson</surname>, <given-names>W.E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li C."><surname>Li</surname>, <given-names>C.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Rabinovic A."><surname>Rabinovic</surname>, <given-names>A.</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-35">Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>, <source hwp:id="source-34">Biostatistics</source>, <volume>8</volume>, <fpage>118</fpage>–<lpage>127</lpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Kanehisa M."><surname>Kanehisa</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title hwp:id="article-title-36">KEGG for integration and interpretation of large-scale molecular data sets</article-title>, <source hwp:id="source-35">Nucleic Acids Res</source>, <volume>40</volume>, <fpage>D109</fpage>–<lpage>114</lpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Keane M.P."><surname>Keane</surname>, <given-names>M.P.</given-names></string-name>, <etal>et al.</etal> (<year>2004</year>) <article-title hwp:id="article-title-37">Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer</article-title>, <source hwp:id="source-36">The Journal of Immunology</source>, <volume>172</volume>, <fpage>2853</fpage>–<lpage>2860</lpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Li X."><surname>Li</surname>, <given-names>X.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-38">Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway</article-title>, <source hwp:id="source-37">PLoS ONE</source>, <volume>10</volume>, <fpage>e0132813</fpage>.</citation></ref><ref id="c38" hwp:id="ref-38"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Liaw A."><surname>Liaw</surname>, <given-names>A.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Wiener M."><surname>Wiener</surname>, <given-names>M.</given-names></string-name> (<year>2002</year>) <article-title hwp:id="article-title-39">Classification and regression by randomForest</article-title>, <source hwp:id="source-38">R news</source>, <volume>2</volume>, <fpage>18</fpage>–<lpage>22</lpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Livshits A."><surname>Livshits</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-40">Pathway-based personalized analysis of breast cancer expression data</article-title>, <source hwp:id="source-39">Molecular oncology</source>, <volume>9</volume>, <fpage>1471</fpage>–<lpage>1483</lpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Losada A."><surname>Losada</surname>, <given-names>A.</given-names></string-name> (<year>2014</year>) <article-title hwp:id="article-title-41">Cohesin in cancer: chromosome segregation and beyond</article-title>, <source hwp:id="source-40">Nature Reviews Cancer</source>, <volume>14</volume>, <fpage>389</fpage>–<lpage>393</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Lu W."><surname>Lu</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>) <article-title hwp:id="article-title-42">Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor a and risk of gastric cancer in a Chinese population</article-title>, <source hwp:id="source-41">Carcinogenesis</source>, <volume>26</volume>, <fpage>631</fpage>–<lpage>636</lpage>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Martini P."><surname>Martini</surname>, <given-names>P.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-43">Along signal paths: an empirical gene set approach exploiting pathway topology</article-title>, <source hwp:id="source-42">Nucleic Acids Res</source>, <volume>41</volume>, <fpage>e19</fpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Matthews J.M."><surname>Matthews</surname>, <given-names>J.M.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-44">LIM-domain-only proteins in cancer</article-title>, <source hwp:id="source-43">Nature Reviews Cancer</source>, <volume>13</volume>, <fpage>111</fpage>–<lpage>122</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Montaner D."><surname>Montaner</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>) <article-title hwp:id="article-title-45">Gene set internal coherence in the context of functional profiling</article-title>, <source hwp:id="source-44">BMC Genomics</source>, <volume>10</volume>, <fpage>197</fpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Montañez-Wiscovich M."><surname>Montañez-Wiscovich</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>) <article-title hwp:id="article-title-46">LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression</article-title>, <source hwp:id="source-45">Oncogene</source>, <volume>28</volume>, <fpage>3608</fpage>–<lpage>3618</lpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Olichon A."><surname>Olichon</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2003</year>) <article-title hwp:id="article-title-47">Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis</article-title>, <source hwp:id="source-46">Journal of Biological Chemistry</source>, <volume>278</volume>, <fpage>7743</fpage>–<lpage>7746</lpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Oti M."><surname>Oti</surname>, <given-names>M.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Brunner H.G."><surname>Brunner</surname>, <given-names>H.G.</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-48">The modular nature of genetic diseases</article-title>, <source hwp:id="source-47">Clin Genet</source>, <volume>71</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Paik S."><surname>Paik</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2004</year>) <article-title hwp:id="article-title-49">A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer</article-title>, <source hwp:id="source-48">New England Journal of Medicine</source>, <volume>351</volume>, <fpage>2817</fpage>–<lpage>2826</lpage>.</citation></ref><ref id="c49" hwp:id="ref-49"><citation publication-type="book" citation-type="book" ref:id="132357v1.49" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Ripley B.D."><surname>Ripley</surname>, <given-names>B.D.</given-names></string-name> (<year>2007</year>) <source hwp:id="source-49">Pattern recognition and neural networks</source>. <publisher-name>Cambridge university press</publisher-name>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Robinson M.D."><surname>Robinson</surname>, <given-names>M.D.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Oshlack A"><surname>Oshlack</surname>, <given-names>A</given-names></string-name>. (<year>2010</year>) <article-title hwp:id="article-title-50">A scaling normalization method for differential expression analysis of RNA-seq data</article-title>, <source hwp:id="source-50">Genome Biol</source>, <volume>11</volume>, <fpage>R25</fpage>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Sebastian-Leon P."><surname>Sebastian-Leon</surname>, <given-names>P.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title hwp:id="article-title-51">Understanding disease mechanisms with models of signaling pathway activities</article-title>, <source hwp:id="source-51">BMC Syst Biol</source>, <volume>8</volume>, <fpage>121</fpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Semenza G.L."><surname>Semenza</surname>, <given-names>G.L.</given-names></string-name> (<year>2012</year>) <article-title hwp:id="article-title-52">Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy</article-title>, <source hwp:id="source-52">Trends in pharmacological sciences</source>, <volume>33</volume>, <fpage>207</fpage>–<lpage>214</lpage>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Shihab H.A."><surname>Shihab</surname>, <given-names>H.A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-53">An integrative approach to predicting the functional effects of non-coding and coding sequence variation</article-title>, <source hwp:id="source-53">Bioinformatics</source>, <volume>31</volume>, <fpage>1536</fpage>–<lpage>1543</lpage>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Sing T."><surname>Sing</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>) <article-title hwp:id="article-title-54">ROCR: visualizing classifier performance in R</article-title>, <source hwp:id="source-54">Bioinformatics</source>, <volume>21</volume>, <fpage>3940</fpage>–<lpage>3941</lpage>.</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Sotiriou C."><surname>Sotiriou</surname>, <given-names>C.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Pusztai L."><surname>Pusztai</surname>, <given-names>L.</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-55">Gene-expression signatures in breast cancer</article-title>, <source hwp:id="source-55">New England Journal of Medicine</source>, <volume>360</volume>, <fpage>790</fpage>–<lpage>800</lpage>.</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><citation publication-type="other" citation-type="journal" ref:id="132357v1.56" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Stelzer G."><surname>Stelzer</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title hwp:id="article-title-56">The genecards suite: from gene data mining to disease genome sequence analyses</article-title>, <source hwp:id="source-56">Current protocols in bioinformatics</source>, <fpage>1.30. 31</fpage>–<lpage>31.30. 33</lpage>.</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Sum E.Y."><surname>Sum</surname>, <given-names>E.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2002</year>) <article-title hwp:id="article-title-57">The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity</article-title>, <source hwp:id="source-57">Journal of Biological Chemistry</source>, <volume>277</volume>, <fpage>7849</fpage>–<lpage>7856</lpage>.</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Sutherland K.D."><surname>Sutherland</surname>, <given-names>K.D.</given-names></string-name>, <etal>et al.</etal> (<year>2003</year>) <article-title hwp:id="article-title-58">Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas</article-title>, <source hwp:id="source-58">International journal of cancer</source>, <volume>107</volume>, <fpage>155</fpage>–<lpage>158</lpage>.</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Testa J.R."><surname>Testa</surname>, <given-names>J.R.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Bellacosa A."><surname>Bellacosa</surname>, <given-names>A.</given-names></string-name> (<year>2001</year>) <article-title hwp:id="article-title-59">AKT plays a central role in tumorigenesis</article-title>, <source hwp:id="source-59">Proceedings of the National Academy of Sciences</source>, <volume>98</volume>, <fpage>10983</fpage>–<lpage>10985</lpage>.</citation></ref><ref id="c60" hwp:id="ref-60"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Tibshirani R."><surname>Tibshirani</surname>, <given-names>R.</given-names></string-name>, <etal>et al.</etal> (<year>2002</year>) <article-title hwp:id="article-title-60">Diagnosis of multiple cancer types by shrunken centroids of gene expression</article-title>, <source hwp:id="source-60">Proceedings of the National Academy of Sciences</source>, <volume>99</volume>, <fpage>6567</fpage>–<lpage>6572</lpage>.</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Tillgren V."><surname>Tillgren</surname>, <given-names>V.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title hwp:id="article-title-61">The novel small leucine-rich protein chondroadherin-like (CHADL) is expressed in cartilage and modulates chondrocyte differentiation</article-title>, <source hwp:id="source-61">Journal of Biological Chemistry</source>, <volume>290</volume>, <fpage>918</fpage>–<lpage>925</lpage>.</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1 xref-ref-62-2"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><collab hwp:id="collab-1">UniProt_Consortium</collab> (<year>2015</year>) <article-title hwp:id="article-title-62">UniProt: a hub for protein information</article-title>, <source hwp:id="source-62">Nucleic Acids Res</source>, <volume>43</volume>, <fpage>D204</fpage>–<lpage>212</lpage>.</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="van’t Veer L.J."><surname>van’t Veer</surname>, <given-names>L.J.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Bernards R."><surname>Bernards</surname>, <given-names>R.</given-names></string-name> (<year>2008</year>) <article-title hwp:id="article-title-63">Enabling personalized cancer medicine through analysis of gene-expression patterns</article-title>, <source hwp:id="source-63">Nature</source>, <volume>452</volume>, <fpage>564</fpage>–<lpage>570</lpage>.</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="van’t Veer L.J."><surname>van’t Veer</surname>, <given-names>L.J.</given-names></string-name>, <etal>et al.</etal> (<year>2002</year>) <article-title hwp:id="article-title-64">Gene expression profiling predicts clinical outcome of breast cancer</article-title>, <source hwp:id="source-64">Nature</source>, <volume>415</volume>, <fpage>530</fpage>–<lpage>536</lpage>.</citation></ref><ref id="c65" hwp:id="ref-65"><citation publication-type="book" citation-type="book" ref:id="132357v1.65" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Venables W."><surname>Venables</surname>, <given-names>W.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Ripley B."><surname>Ripley</surname>, <given-names>B.</given-names></string-name> (<year>2002</year>) <source hwp:id="source-65">Modern Applied Statistics with S</source>. <publisher-name>Springer</publisher-name>, <publisher-loc>New York</publisher-loc>.</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Vidal M."><surname>Vidal</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cusick M.E."><surname>Cusick</surname>, <given-names>M.E.</given-names></string-name> and <string-name name-style="western" hwp:sortable="Barabasi A.L"><surname>Barabasi</surname>, <given-names>A.L</given-names></string-name>. (<year>2011</year>) <article-title hwp:id="article-title-65">Interactome networks and human disease</article-title>, <source hwp:id="source-66">Cell</source>, <volume>144</volume>, <fpage>986</fpage>–<lpage>998</lpage>.</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Wang Y."><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>) <article-title hwp:id="article-title-66">Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer</article-title>, <source hwp:id="source-67">The Lancet</source>, <volume>365</volume>, <fpage>671</fpage>–<lpage>679</lpage>.</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Wilson B.J."><surname>Wilson</surname>, <given-names>B.J.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title hwp:id="article-title-67">ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit</article-title>, <source hwp:id="source-68">Cancer research</source>, <volume>74</volume>, <fpage>4196</fpage>–<lpage>4207</lpage>.</citation></ref><ref id="c69" hwp:id="ref-69" hwp:rev-id="xref-ref-69-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.69" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-69"><string-name name-style="western" hwp:sortable="Yang H."><surname>Yang</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title hwp:id="article-title-68">Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis</article-title>, <source hwp:id="source-69">PLoS ONE</source>, <volume>9</volume>, <fpage>e109980</fpage>.</citation></ref><ref id="c70" hwp:id="ref-70" hwp:rev-id="xref-ref-70-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.70" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-70"><string-name name-style="western" hwp:sortable="Yang J.Y."><surname>Yang</surname>, <given-names>J.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>) <article-title hwp:id="article-title-69">p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance</article-title>, <source hwp:id="source-70">BMC Cancer</source>, <volume>10</volume>, <fpage>388</fpage>.</citation></ref><ref id="c71" hwp:id="ref-71"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.71" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-71"><string-name name-style="western" hwp:sortable="Zeileis A."><surname>Zeileis</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2004</year>) <article-title hwp:id="article-title-70">kernlab-an S4 package for kernel methods in R</article-title>, <source hwp:id="source-71">Journal of Statistical Software</source>, <volume>11</volume>, <fpage>1</fpage>–<lpage>20</lpage>.</citation></ref><ref id="c72" hwp:id="ref-72" hwp:rev-id="xref-ref-72-1"><citation publication-type="journal" citation-type="journal" ref:id="132357v1.72" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-72"><string-name name-style="western" hwp:sortable="Zhao X."><surname>Zhao</surname>, <given-names>X.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title hwp:id="article-title-71">OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma</article-title>, <source hwp:id="source-72">Laboratory Investigation</source>, <volume>93</volume>, <fpage>8</fpage>–<lpage>19</lpage>.</citation></ref></ref-list></back></article>
